Shlomi Dekel, Benderly Michal, Olmer Liraz, Kalter-Leibovici Ofra
Adelson School of Medicine, Ariel University, Israel.
Pulmonary Clinic, Clalit Health Services Community Division, Ramat-Gan, Israel.
Chron Respir Dis. 2025 Jan-Dec;22:14799731251355445. doi: 10.1177/14799731251355445. Epub 2025 Jun 29.
BackgroundIdentifying clinical and socio-economic predictors of adverse health outcomes in chronic obstructive pulmonary disease (COPD) patients is imperative for reducing exacerbation and mortality rates.MethodsThe COPD Community Disease Management (COPD-CDM) clinical trial evaluated the efficacy of a disease management program among 1202 ambulatory COPD patients receiving recommended care. The study did not find disease management to be superior to recommended care only, in preventing COPD hospital admissions or mortality. This post-hoc analysis examined the association of clinical and socioeconomic parameters with the length of in-hospital stay and all-cause mortality by multivariable non-linear mixed and Cox proportional hazards models, adjusted for age, sex, study arm, recruitment and study period, and medical therapy.ResultsA one-point increment in the Modified Medical Research Council dyspnea scale was associated with a higher hazard for all-cause mortality, (Hazards Ratio [HR]:1.50, 95% confidence interval [CI]: 1.22-1.85); longer in-hospital stay for COPD or all causes; Rate Ratio (95% CI): 1.64 (1.36-1.98), and 1.36 ( 1.19-1.55), respectively. A 50 m increment in six-minute walking distance was associated with fewer days in-hospital for both COPD and all causes; Rate Ratio (95% CI); 0.94 (0.89-0.99) and 0.95 (0.92-0.99), respectively. Unemployment and lower educational attainment were associated with a longer in-hospital stay both for COPD and all causes.ConclusionsClinical and socioeconomic parameters were associated with the number of days in hospital for COPD and all-causes, and all-cause mortality in ambulatory COPD patients. Our findings support the importance of a multi-disciplinary pulmonary approach to improve clinical outcomes among COPD patients.
背景
识别慢性阻塞性肺疾病(COPD)患者不良健康结局的临床和社会经济预测因素对于降低急性加重率和死亡率至关重要。
方法
COPD社区疾病管理(COPD-CDM)临床试验评估了疾病管理项目在1202名接受推荐治疗的非卧床COPD患者中的疗效。该研究未发现疾病管理在预防COPD住院或死亡方面优于单纯推荐治疗。这项事后分析通过多变量非线性混合模型和Cox比例风险模型,在调整年龄、性别、研究组、招募和研究时期以及药物治疗后,研究了临床和社会经济参数与住院时间和全因死亡率之间的关联。
结果
改良医学研究委员会呼吸困难量表增加1分与全因死亡风险较高相关(风险比[HR]:1.50,95%置信区间[CI]:1.22 - 1.85);因COPD或所有原因导致的住院时间更长;率比(95% CI)分别为1.64(1.36 - 1.98)和1.36(1.19 - 1.55)。六分钟步行距离增加50米与因COPD和所有原因导致的住院天数减少相关;率比(95% CI)分别为0.94(0.89 - 0.99)和0.95(0.92 - 0.99)。失业和较低的教育程度与因COPD和所有原因导致的住院时间更长相关。
结论
临床和社会经济参数与非卧床COPD患者因COPD和所有原因导致的住院天数以及全因死亡率相关。我们的研究结果支持多学科肺部治疗方法对于改善COPD患者临床结局的重要性。